Wednesday, March 22, 2017 4:53:55 AM
With the O/S ...
Last R/S here was this:
Capital Change=shs decreased by 1 for 3000 split. Pay date=09/25/2015.
O.K., now let's see the filings:
Common stock, $0.001 par value, 800,000,000 shares authorized;
issued and outstanding 112,964,581 at June 30, 2016 and
107,585,581 at December 31, 2015. 30,2016
Common stock, $0.001 par value, 800,000,000 shares authorized;
issued and outstanding 113,014,581 at September 30, 2016 and
107,585,581 at December 31, 2015. 30,2016
So it's pretty clear that on July 2016 (when we hit 2,13 $) the O/S was around 113 MM, right?
Now see this new from October 2016:
APPSWARM INC. RETIRES MAJORITY OF COMMON SHARES
Tulsa, OK--(OTC Markets News October 28, 2016) – AppSwarm, Inc. (OTC: SWRM) announces the
cancellation of 67,500,000 restricted shares of common stock or 57.3% of the outstanding. This means
shareholders in possession of more than 4,550,000 shares are now classified as affiliates because their
ownership exceeds 10% of the outstanding common stock. Notices have been sent to shareholders’
known to the company to possess such shares and to the brokerage houses at which they reside.
The lateral merger at the state level and the change of control announced in the press release of October
14, 2016 has been completed. The process for completing the name change to AppSwarm Corp. has
begun with the application for a new CUSIP number. Upon receipt of the new CUSIP number the filing
with FINRA will be entered.
That's why you see a O/S of 50 MM at pinksheets.com
113 - 67,5 = 45,5 + 5 MM RESTRICTED GIVEN TO MR.BREWER = 50 MM O/S
SWRM Security Details
Share Structure
Market Value1 $650,193 a/o Mar 14, 2017
Authorized Shares 810,000,000 a/o Oct 05, 2015
Outstanding Shares 50,014,851 a/o Dec 15, 2016
If you have followed all the steps you should be excited right now...by the way, the A/S has been also decreased from 810 to 500 MM.
http://nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=fm%252b3to5vH8jyBFNzTBAuhw%253d%253d&nt7=0
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM